252 related articles for article (PubMed ID: 9166673)
1. Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM.
Perriello G; Pampanelli S; Del Sindaco P; Lalli C; Ciofetta M; Volpi E; Santeusanio F; Brunetti P; Bolli GB
Diabetes; 1997 Jun; 46(6):1010-6. PubMed ID: 9166673
[TBL] [Abstract][Full Text] [Related]
2. Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus.
Boden G; Chen X; Stein TP
Am J Physiol Endocrinol Metab; 2001 Jan; 280(1):E23-30. PubMed ID: 11120655
[TBL] [Abstract][Full Text] [Related]
3. Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study.
Gastaldelli A; Baldi S; Pettiti M; Toschi E; Camastra S; Natali A; Landau BR; Ferrannini E
Diabetes; 2000 Aug; 49(8):1367-73. PubMed ID: 10923639
[TBL] [Abstract][Full Text] [Related]
4. Glutamine and alanine metabolism in NIDDM.
Stumvoll M; Perriello G; Nurjhan N; Bucci A; Welle S; Jansson PA; Dailey G; Bier D; Jenssen T; Gerich J
Diabetes; 1996 Jul; 45(7):863-8. PubMed ID: 8666134
[TBL] [Abstract][Full Text] [Related]
5. Effect of glycemic control on glucose counterregulation during hypoglycemia in NIDDM.
Levy CJ; Kinsley BT; Bajaj M; Simonson DC
Diabetes Care; 1998 Aug; 21(8):1330-8. PubMed ID: 9702443
[TBL] [Abstract][Full Text] [Related]
6. Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes.
Boden G; Chen X; Capulong E; Mozzoli M
Diabetes; 2001 Apr; 50(4):810-6. PubMed ID: 11289046
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of lipolysis decreases lipid oxidation and gluconeogenesis from lactate but not fasting hyperglycemia or total hepatic glucose production in NIDDM.
Puhakainen I; Yki-Järvinen H
Diabetes; 1993 Dec; 42(12):1694-9. PubMed ID: 8243814
[TBL] [Abstract][Full Text] [Related]
8. Evidence for increased liver glycogen in patients with noninsulin-dependent diabetes mellitus after a 3-day fast.
Clore JN; Post EP; Bailey DJ; Nestler JE; Blackard WG
J Clin Endocrinol Metab; 1992 Mar; 74(3):660-6. PubMed ID: 1740502
[TBL] [Abstract][Full Text] [Related]
9. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM.
Consoli A; Nurjhan N; Capani F; Gerich J
Diabetes; 1989 May; 38(5):550-7. PubMed ID: 2653926
[TBL] [Abstract][Full Text] [Related]
10. Suppression of gluconeogenesis after a 3-day fast does not deplete liver glycogen in patients with NIDDM.
Clore JN; Blackard WG
Diabetes; 1994 Feb; 43(2):256-62. PubMed ID: 8288050
[TBL] [Abstract][Full Text] [Related]
11. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.
Vaag A; Alford F; Henriksen FL; Christopher M; Beck-Nielsen H
Diabetologia; 1995 Mar; 38(3):326-36. PubMed ID: 7758880
[TBL] [Abstract][Full Text] [Related]
12. Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients.
Gastaldelli A; Toschi E; Pettiti M; Frascerra S; Quiñones-Galvan A; Sironi AM; Natali A; Ferrannini E
Diabetes; 2001 Aug; 50(8):1807-12. PubMed ID: 11473042
[TBL] [Abstract][Full Text] [Related]
13. Lipolysis and gluconeogenesis from glycerol are increased in patients with noninsulin-dependent diabetes mellitus.
Puhakainen I; Koivisto VA; Yki-Järvinen H
J Clin Endocrinol Metab; 1992 Sep; 75(3):789-94. PubMed ID: 1517368
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism.
Consoli A; Nurjhan N; Reilly JJ; Bier DM; Gerich JE
J Clin Invest; 1990 Dec; 86(6):2038-45. PubMed ID: 2254458
[TBL] [Abstract][Full Text] [Related]
15. Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus.
Nurjhan N; Consoli A; Gerich J
J Clin Invest; 1992 Jan; 89(1):169-75. PubMed ID: 1729269
[TBL] [Abstract][Full Text] [Related]
16. Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans. Demonstration of hepatic autoregulation without a change in plasma glucose concentration.
Jenssen T; Nurjhan N; Consoli A; Gerich JE
J Clin Invest; 1990 Aug; 86(2):489-97. PubMed ID: 2200805
[TBL] [Abstract][Full Text] [Related]
17. Assessment of hepatic sensitivity to glucagon in NIDDM: use as a tool to estimate the contribution of the indirect pathway to nocturnal glycogen synthesis.
Nielsen MF; Wise S; Dinneen SF; Schwenk WF; Basu A; Rizza RA
Diabetes; 1997 Dec; 46(12):2007-16. PubMed ID: 9392488
[TBL] [Abstract][Full Text] [Related]
18. Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
Rachman J; Gribble FM; Barrow BA; Levy JC; Buchanan KD; Turner RC
Diabetes; 1996 Nov; 45(11):1524-30. PubMed ID: 8866556
[TBL] [Abstract][Full Text] [Related]
19. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
Toft I; Jenssen T
Scand J Clin Lab Invest; 2005; 65(4):307-20. PubMed ID: 16076686
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive tracing of liver intermediary metabolism in normal subjects and in moderately hyperglycaemic NIDDM subjects. Evidence against increased gluconeogenesis and hepatic fatty acid oxidation in NIDDM.
Diraison F; Large V; Brunengraber H; Beylot M
Diabetologia; 1998 Feb; 41(2):212-20. PubMed ID: 9498656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
